Viral Polypeptides and Methods
The invention is directed to polypeptides and polypeptide fragments from HIV- 1 envelope (Env) proteins following the characterisation of Env structures from environments where HIV isolates expose conserved neutralisation- sensitive Env structures. There is provided a polypeptide being all or a fragment of an HIV-1 envelope protein from a transmission strain of HIV-1, the polypeptide having neutralisation sensitive epitopes that are accessible.
Patents:WO 2,010,031,113
Inventor(s):
PURCELL DAMIAN [AU]; CENTER ROBERT [AU]; REDDY SHARMILA MOHANA RAMA [AU]
Type of Offer:
Sale
« More Medical Patents